Anbio Biotechnology (NNNN) — Institutional Holders, Q2 2026
12 institutional investment managers reported a NNNN position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $985.2K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
NNNN in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- BANK OF AMERICANew · +13,419 sh+$184.0K
- MARSHALL WACE, LLPNew · +11,502 sh+$157.7K
- BNP PARIBAS FINANCIAL MARKETSAdded · +1,400 sh+$19.2K
- GEODE CAPITAL MANAGEMENTAdded · +973 sh+$13.3K
- OSAICNew · +77 sh+$1.1K
Biggest sellers
- UBS Group AGTrimmed · -5,511 sh-$75.6K
- MORGAN STANLEYTrimmed · -107 sh-$1.5K
- WELLS FARGO & COMPANYSold out · -100 sh-$1.4K
- Ronald BlueSold out · -5 sh-$69.00
NNNN 13F holders ranked 1–12 of 12
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT#1 · 26,736 sh | 26,736 | $366.6K | 0.00% | +3.8% |
| 2 | BANK OF AMERICA#2 · 13,419 sh | 13,419 | $184.0K | 0.00% | New |
| 3 | BNP PARIBAS FINANCIAL MARKETS#3 · 11,800 sh | 11,800 | $161.8K | <0.01% | +13.5% |
| 4 | MARSHALL WACE, LLP#4 · 11,502 sh | 11,502 | $157.7K | <0.01% | New |
| 5 | MORGAN STANLEY#5 · 7,231 sh | 7,231 | $99.1K | 0.00% | -1.5% |
| 6 | UBS Group AG#6 · 828 sh | 828 | $11.4K | 0.00% | -86.9% |
| 7 | EverSource Wealth Advisors#7 · 187 sh | 187 | $2.6K | <0.01% | -86.9% |
| 8 | OSAIC#8 · 77 sh | 77 | $1.1K | 0.00% | New |
| 9 | JPMORGAN CHASE#9 · 53 sh | 53 | $718.00 | 0.00% | New |
| 10 | Bare Financial Services#10 · 15 sh | 15 | $206.00 | 0.00% | 0.0% |
| 11 | Larson Financial Group#11 · 5 sh | 5 | $69.00 | 0.00% | New |
| 12 | Silver Grove Financial Group#12 · 4 sh | 4 | $55.00 | 0.00% | New |
Funds that sold out of NNNN in Q2 2026 (2)
Held NNNN at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| WELLS FARGO & COMPANY100 sh | 100 | $2.6K |
| Ronald Blue5 sh | 5 | $128.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.